Collectively, our present findings provide at least two mechanistic insights into the roles of SRC-3 in MM drug resistance, and also provide a perspective for better understanding how SRC-3 bridges chromatin modifications with transcriptional alterations to promote chemoresistance in MM. This evidence concerns the gene NCOA3 and Miyoshi myopathy.